Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody

• Sandeep S. Patil ,

  Contributed equally to this work with: Sandeep S. Patil, Ivaylo Gentschev

  Affiliation Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Ivaylo Gentschev ,

  Contributed equally to this work with: Sandeep S. Patil, Ivaylo Gentschev

  Affiliations Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany, Genelux Corporation, San Diego Science Center, San Diego, California, United States of America

  ⨯
• Marion Adelfinger,

  Affiliation Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Ulrike Donat,

  Affiliation Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Michael Hess,

  Affiliation Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Stephanie Weibel,

  Affiliation Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany

  ⨯
• Ingo Nolte,

  Affiliation Small Animal Clinic, University of Veterinary Medicine, Hannover, Germany

  ⨯
• Alexa Frentzen,

  Affiliation Genelux Corporation, San Diego Science Center, San Diego, California, United States of America

  ⨯
• Aladar A. Szalay

  * E-mail: aaszalay@genelux.com

  Affiliations Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany, Genelux Corporation, San Diego Science Center, San Diego, California, United States of America, Rudolf Virchow Center for Experimental Biomedicine, University of Wuerzburg, Wuerzburg, Germany, Institute for Molecular Infection Biology, University of Wuerzburg, Wuerzburg, Germany, Department of Radiation Oncology, Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯